HEADER TRANSFERASE 21-AUG-01 1JTQ TITLE E. COLI TS COMPLEX WITH DUMP AND THE PYRROLO(2,3-D)PYRIMIDINE-BASED TITLE 2 ANTIFOLATE LY341770 COMPND MOL_ID: 1; COMPND 2 MOLECULE: THYMIDYLATE SYNTHASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: TS; COMPND 5 EC: 2.1.1.45; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 GENE: THYA; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: X2913; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PTHYA-WT KEYWDS ANTIFOLATE, CANCER, DRUG RESISTANCE, DTMP SYNTHESIS, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR P.H.SAYRE,J.S.FINER-MOORE,T.A.FRITZ,D.BIERMANN,S.B.GATES, AUTHOR 2 W.C.MACKELLAR,V.F.PATEL,R.M.STROUD REVDAT 7 16-AUG-23 1JTQ 1 REMARK SEQADV LINK REVDAT 6 11-OCT-17 1JTQ 1 REMARK REVDAT 5 13-JUL-11 1JTQ 1 VERSN REVDAT 4 24-FEB-09 1JTQ 1 VERSN REVDAT 3 28-AUG-02 1JTQ 1 ATOM REVDAT 2 14-NOV-01 1JTQ 1 JRNL REVDAT 1 19-SEP-01 1JTQ 0 JRNL AUTH P.H.SAYRE,J.S.FINER-MOORE,T.A.FRITZ,D.BIERMANN,S.B.GATES, JRNL AUTH 2 W.C.MACKELLAR,V.F.PATEL,R.M.STROUD JRNL TITL MULTI-TARGETED ANTIFOLATES AIMED AT AVOIDING DRUG RESISTANCE JRNL TITL 2 FORM COVALENT CLOSED INHIBITORY COMPLEXES WITH HUMAN AND JRNL TITL 3 ESCHERICHIA COLI THYMIDYLATE SYNTHASES. JRNL REF J.MOL.BIOL. V. 313 813 2001 JRNL REFN ISSN 0022-2836 JRNL PMID 11697906 JRNL DOI 10.1006/JMBI.2001.5074 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH C.A.SCHIFFER,I.J.CLIFTON,V.J.DAVISSON,D.V.SANTI,R.M.STROUD REMARK 1 TITL CRYSTAL STRUCTURE OF HUMAN THYMIDYLATE SYNTHASE: A REMARK 1 TITL 2 STRUCTURAL MECHANISM FOR GUIDING SUBSTRATES INTO THE ACTIVE REMARK 1 TITL 3 SITE REMARK 1 REF BIOCHEMISTRY V. 34 16279 1995 REMARK 1 REFN ISSN 0006-2960 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.89 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 140967.480 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 21792 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.219 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2165 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.66 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3126 REMARK 3 BIN R VALUE (WORKING SET) : 0.2790 REMARK 3 BIN FREE R VALUE : 0.3310 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 341 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.018 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4306 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 106 REMARK 3 SOLVENT ATOMS : 102 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 10.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.59000 REMARK 3 B22 (A**2) : -0.59000 REMARK 3 B33 (A**2) : 1.17000 REMARK 3 B12 (A**2) : 1.12000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM SIGMAA (A) : 0.40 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.48 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.200 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.30 REMARK 3 BSOL : 38.28 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : LY341770_062998.PAR REMARK 3 PARAMETER FILE 4 : PARAMED.LIG REMARK 3 PARAMETER FILE 5 : FORM.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : LY341770_062998.TOP REMARK 3 TOPOLOGY FILE 4 : TOPO_COVALENT.DUMP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1JTQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-AUG-01. REMARK 100 THE DEPOSITION ID IS D_1000014173. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-APR-97 REMARK 200 TEMPERATURE (KELVIN) : 296 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS II REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21792 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : 0.10900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.57 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.38500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: PDB ENTRY 2KCE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.15 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: POTASSIUM PHOSPHATE, MGCL2, DTT, EDTA, REMARK 280 AMMONIUM SULFATE, PH 8.0, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 296.16K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 63 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/2 REMARK 290 6555 X-Y,X,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 34.05000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 34.05000 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 34.05000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7870 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19140 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -12.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 43 63.74 -66.05 REMARK 500 GLU A 74 3.23 -69.88 REMARK 500 PRO A 92 65.90 -68.18 REMARK 500 TYR A 94 -63.91 -29.02 REMARK 500 ALA A 100 66.51 -156.62 REMARK 500 ILE B 69 0.39 -69.10 REMARK 500 VAL B 93 -165.03 -78.91 REMARK 500 TYR B 94 -61.93 -26.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UMP A 565 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LY3 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UMP B 565 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LY3 B 502 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1JTU RELATED DB: PDB REMARK 900 E. COLI TS COMPLEX WITH DUMP AND A POLYGLUTAMYLATED FORM OF LY231514 REMARK 900 RELATED ID: 1JU6 RELATED DB: PDB REMARK 900 P1 CRYSTAL FORM OF HUMAN THYMIDYLATE SYNTHASE COMPLEX WITH DUMP AND REMARK 900 LY231514 REMARK 900 RELATED ID: 1JUJ RELATED DB: PDB REMARK 900 HUMAN THYMIDYLATE SYNTHASE BOUND TO DUMP AND LY231514, A PYRROLO(2, REMARK 900 3-D)PYRIMIDINE-BASED ANTIFOLATE DBREF 1JTQ A 1 264 UNP P0A884 TYSY_ECOLI 1 264 DBREF 1JTQ B 1 264 UNP P0A884 TYSY_ECOLI 1 264 SEQADV 1JTQ CXM A 1 UNP P0A884 MET 1 MODIFIED RESIDUE SEQADV 1JTQ CXM B 1 UNP P0A884 MET 1 MODIFIED RESIDUE SEQRES 1 A 264 CXM LYS GLN TYR LEU GLU LEU MET GLN LYS VAL LEU ASP SEQRES 2 A 264 GLU GLY THR GLN LYS ASN ASP ARG THR GLY THR GLY THR SEQRES 3 A 264 LEU SER ILE PHE GLY HIS GLN MET ARG PHE ASN LEU GLN SEQRES 4 A 264 ASP GLY PHE PRO LEU VAL THR THR LYS ARG CYS HIS LEU SEQRES 5 A 264 ARG SER ILE ILE HIS GLU LEU LEU TRP PHE LEU GLN GLY SEQRES 6 A 264 ASP THR ASN ILE ALA TYR LEU HIS GLU ASN ASN VAL THR SEQRES 7 A 264 ILE TRP ASP GLU TRP ALA ASP GLU ASN GLY ASP LEU GLY SEQRES 8 A 264 PRO VAL TYR GLY LYS GLN TRP ARG ALA TRP PRO THR PRO SEQRES 9 A 264 ASP GLY ARG HIS ILE ASP GLN ILE THR THR VAL LEU ASN SEQRES 10 A 264 GLN LEU LYS ASN ASP PRO ASP SER ARG ARG ILE ILE VAL SEQRES 11 A 264 SER ALA TRP ASN VAL GLY GLU LEU ASP LYS MET ALA LEU SEQRES 12 A 264 ALA PRO CYS HIS ALA PHE PHE GLN PHE TYR VAL ALA ASP SEQRES 13 A 264 GLY LYS LEU SER CYS GLN LEU TYR GLN ARG SER CYS ASP SEQRES 14 A 264 VAL PHE LEU GLY LEU PRO PHE ASN ILE ALA SER TYR ALA SEQRES 15 A 264 LEU LEU VAL HIS MET MET ALA GLN GLN CYS ASP LEU GLU SEQRES 16 A 264 VAL GLY ASP PHE VAL TRP THR GLY GLY ASP THR HIS LEU SEQRES 17 A 264 TYR SER ASN HIS MET ASP GLN THR HIS LEU GLN LEU SER SEQRES 18 A 264 ARG GLU PRO ARG PRO LEU PRO LYS LEU ILE ILE LYS ARG SEQRES 19 A 264 LYS PRO GLU SER ILE PHE ASP TYR ARG PHE GLU ASP PHE SEQRES 20 A 264 GLU ILE GLU GLY TYR ASP PRO HIS PRO GLY ILE LYS ALA SEQRES 21 A 264 PRO VAL ALA ILE SEQRES 1 B 264 CXM LYS GLN TYR LEU GLU LEU MET GLN LYS VAL LEU ASP SEQRES 2 B 264 GLU GLY THR GLN LYS ASN ASP ARG THR GLY THR GLY THR SEQRES 3 B 264 LEU SER ILE PHE GLY HIS GLN MET ARG PHE ASN LEU GLN SEQRES 4 B 264 ASP GLY PHE PRO LEU VAL THR THR LYS ARG CYS HIS LEU SEQRES 5 B 264 ARG SER ILE ILE HIS GLU LEU LEU TRP PHE LEU GLN GLY SEQRES 6 B 264 ASP THR ASN ILE ALA TYR LEU HIS GLU ASN ASN VAL THR SEQRES 7 B 264 ILE TRP ASP GLU TRP ALA ASP GLU ASN GLY ASP LEU GLY SEQRES 8 B 264 PRO VAL TYR GLY LYS GLN TRP ARG ALA TRP PRO THR PRO SEQRES 9 B 264 ASP GLY ARG HIS ILE ASP GLN ILE THR THR VAL LEU ASN SEQRES 10 B 264 GLN LEU LYS ASN ASP PRO ASP SER ARG ARG ILE ILE VAL SEQRES 11 B 264 SER ALA TRP ASN VAL GLY GLU LEU ASP LYS MET ALA LEU SEQRES 12 B 264 ALA PRO CYS HIS ALA PHE PHE GLN PHE TYR VAL ALA ASP SEQRES 13 B 264 GLY LYS LEU SER CYS GLN LEU TYR GLN ARG SER CYS ASP SEQRES 14 B 264 VAL PHE LEU GLY LEU PRO PHE ASN ILE ALA SER TYR ALA SEQRES 15 B 264 LEU LEU VAL HIS MET MET ALA GLN GLN CYS ASP LEU GLU SEQRES 16 B 264 VAL GLY ASP PHE VAL TRP THR GLY GLY ASP THR HIS LEU SEQRES 17 B 264 TYR SER ASN HIS MET ASP GLN THR HIS LEU GLN LEU SER SEQRES 18 B 264 ARG GLU PRO ARG PRO LEU PRO LYS LEU ILE ILE LYS ARG SEQRES 19 B 264 LYS PRO GLU SER ILE PHE ASP TYR ARG PHE GLU ASP PHE SEQRES 20 B 264 GLU ILE GLU GLY TYR ASP PRO HIS PRO GLY ILE LYS ALA SEQRES 21 B 264 PRO VAL ALA ILE MODRES 1JTQ CXM A 1 MET N-CARBOXYMETHIONINE MODRES 1JTQ CXM B 1 MET N-CARBOXYMETHIONINE HET CXM A 1 11 HET CXM B 1 11 HET UMP A 565 20 HET LY3 A 501 33 HET UMP B 565 20 HET LY3 B 502 33 HETNAM CXM N-CARBOXYMETHIONINE HETNAM UMP 2'-DEOXYURIDINE 5'-MONOPHOSPHATE HETNAM LY3 2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3- HETNAM 2 LY3 D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-4-(2H-TETRAZOL- HETNAM 3 LY3 5-YL)-BUTYRIC ACID HETSYN UMP DUMP HETSYN LY3 LY341770 FORMUL 1 CXM 2(C6 H11 N O4 S) FORMUL 3 UMP 2(C9 H13 N2 O8 P) FORMUL 4 LY3 2(C20 H21 N9 O4) FORMUL 7 HOH *102(H2 O) HELIX 1 1 CXM A 1 GLY A 15 1 15 HELIX 2 2 HIS A 51 GLN A 64 1 14 HELIX 3 3 ILE A 69 GLU A 74 1 6 HELIX 4 4 TRP A 80 ALA A 84 5 5 HELIX 5 5 VAL A 93 ALA A 100 1 8 HELIX 6 6 ASP A 110 ASP A 122 1 13 HELIX 7 7 ASN A 134 MET A 141 5 8 HELIX 8 8 LEU A 172 CYS A 192 1 21 HELIX 9 9 HIS A 212 SER A 221 1 10 HELIX 10 10 ARG A 243 GLU A 245 5 3 HELIX 11 11 CXM B 1 GLY B 15 1 15 HELIX 12 12 GLN B 39 GLY B 41 5 3 HELIX 13 13 HIS B 51 GLY B 65 1 15 HELIX 14 14 ILE B 69 ASN B 75 1 7 HELIX 15 15 TRP B 80 ALA B 84 5 5 HELIX 16 16 VAL B 93 ALA B 100 1 8 HELIX 17 17 ASP B 110 ASP B 122 1 13 HELIX 18 18 ASN B 134 MET B 141 5 8 HELIX 19 19 LEU B 172 CYS B 192 1 21 HELIX 20 20 HIS B 212 SER B 221 1 10 HELIX 21 21 SER B 238 TYR B 242 5 5 HELIX 22 22 ARG B 243 GLU B 245 5 3 SHEET 1 A 6 THR A 16 LYS A 18 0 SHEET 2 A 6 THR A 26 ASN A 37 -1 O THR A 26 N LYS A 18 SHEET 3 A 6 GLU A 195 TYR A 209 -1 O GLY A 203 N HIS A 32 SHEET 4 A 6 LYS A 158 ASP A 169 1 N GLN A 165 O THR A 202 SHEET 5 A 6 HIS A 147 ALA A 155 -1 N PHE A 149 O TYR A 164 SHEET 6 A 6 ILE A 129 SER A 131 -1 N VAL A 130 O PHE A 150 SHEET 1 B 2 TRP A 101 PRO A 102 0 SHEET 2 B 2 HIS A 108 ILE A 109 -1 O ILE A 109 N TRP A 101 SHEET 1 C 2 LYS A 229 ILE A 232 0 SHEET 2 C 2 PHE A 247 GLU A 250 -1 O GLU A 248 N ILE A 231 SHEET 1 D 6 THR B 16 LYS B 18 0 SHEET 2 D 6 THR B 26 ASN B 37 -1 O THR B 26 N LYS B 18 SHEET 3 D 6 GLU B 195 TYR B 209 -1 O TRP B 201 N MET B 34 SHEET 4 D 6 LYS B 158 ASP B 169 1 N LEU B 159 O GLU B 195 SHEET 5 D 6 HIS B 147 ALA B 155 -1 N PHE B 149 O TYR B 164 SHEET 6 D 6 ILE B 129 SER B 131 -1 N VAL B 130 O PHE B 150 SHEET 1 E 2 TRP B 101 PRO B 102 0 SHEET 2 E 2 HIS B 108 ILE B 109 -1 O ILE B 109 N TRP B 101 SHEET 1 F 2 LYS B 229 ILE B 232 0 SHEET 2 F 2 PHE B 247 GLU B 250 -1 O GLU B 248 N ILE B 231 LINK C CXM A 1 N LYS A 2 1555 1555 1.31 LINK SG CYS A 146 C6 UMP A 565 1555 1555 1.84 LINK C CXM B 1 N LYS B 2 1555 1555 1.32 LINK SG CYS B 146 C6 UMP B 565 1555 1555 1.85 SITE 1 AC1 15 ARG A 21 CYS A 146 HIS A 147 GLN A 165 SITE 2 AC1 15 ARG A 166 SER A 167 ASP A 169 ASN A 177 SITE 3 AC1 15 HIS A 207 TYR A 209 LY3 A 501 HOH A 602 SITE 4 AC1 15 HOH A 655 ARG B 126 ARG B 127 SITE 1 AC2 12 HIS A 51 SER A 54 ILE A 79 TRP A 83 SITE 2 AC2 12 LEU A 143 ASP A 169 GLY A 173 LYS A 259 SITE 3 AC2 12 ALA A 263 UMP A 565 HOH A 623 HOH A 658 SITE 1 AC3 16 ARG A 126 ARG A 127 ARG B 21 CYS B 146 SITE 2 AC3 16 HIS B 147 GLN B 165 ARG B 166 SER B 167 SITE 3 AC3 16 CYS B 168 ASP B 169 ASN B 177 HIS B 207 SITE 4 AC3 16 TYR B 209 LY3 B 502 HOH B 659 HOH B 668 SITE 1 AC4 11 HIS B 51 SER B 54 ILE B 79 TRP B 80 SITE 2 AC4 11 TRP B 83 ASP B 169 GLY B 173 TYR B 209 SITE 3 AC4 11 VAL B 262 ALA B 263 UMP B 565 CRYST1 127.800 127.800 68.100 90.00 90.00 120.00 P 63 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007825 0.004518 0.000000 0.00000 SCALE2 0.000000 0.009035 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014684 0.00000 HETATM 1 N CXM A 1 22.151 20.199 49.620 1.00 27.08 N HETATM 2 CA CXM A 1 23.534 20.738 49.674 1.00 29.18 C HETATM 3 CB CXM A 1 24.322 20.384 48.426 1.00 33.82 C HETATM 4 CG CXM A 1 24.628 18.932 48.186 1.00 33.79 C HETATM 5 SD CXM A 1 25.734 18.824 46.798 1.00 32.04 S HETATM 6 CE CXM A 1 24.594 18.833 45.444 1.00 30.78 C HETATM 7 C CXM A 1 23.495 22.206 49.850 1.00 28.05 C HETATM 8 O CXM A 1 22.611 22.847 49.261 1.00 29.54 O HETATM 9 CN CXM A 1 21.861 18.968 49.918 1.00 32.72 C HETATM 10 ON1 CXM A 1 22.654 18.223 50.548 1.00 39.14 O HETATM 11 ON2 CXM A 1 20.721 18.581 49.599 1.00 34.74 O